A strategy for last step [ 18
The fluorinase enzyme, originally isolated from Streptomyces cattleya catalyses the conversion of Sadenosyl-L-methionine (AdoMet) 1 and fluoride ion to 5ʹ-fluoro-5ʹ-deoxyadenosine (FDA) 2 and Lmethionine (L-Met) 3 as illustrated in Scheme 1a. [1] The enzyme has found application in positron emission tomography (PET) due to its ability to catalyse C- [3] and the enzymatic process therefore offers the possibility of directly radiolabelling biomolecules in the aqueous phase. [4] [5] [6] However there is some substrate tolerance to halide. It has previously been shown that ClDA 4 is a better substrate than FDA 2 for the generation of AdoMet (Scheme 1b). [7] This is because chloride is a better leaving group than fluoride, but a poor nucleophile in the forward reaction. Also in these reactions L-selenomethionine (L-SeMet) is a better substrate than L-Met 3, generating AdoSeMet 5 in place of AdoMet 1. More generally the substrate specificity of the fluorinase is poor. All carbon skeletal modifications that have been explored so far lead to substantially reduced kinetics frustrating efficient biocatalysis. We now report a breakthrough in substrate specificity which exploits a structural modification to the substrate, incorporating an acetylene moiety at C-2 of the adenine ring. Close inspection of co-crystal structures of the fluorinase with FDA 2 ( Figure 1 ) [8] indicated that the C-2 adenine hydrogen was positioned in the active site close to the enzyme surface and it was envisaged that a small linear functional group at C-2 should penetrate into the solvent. It appeared most strategic to place an acetylene functionality at C-2 due to its linearity and low steric impact. Thus 5ʹ-chloro-5ʹ-deoxy-2-ethynyladenosine (ClDEA) 6 became a candidate substrate for a transhalogenation reaction. The route developed for the synthesis of 6 is outlined in Scheme 2. Iodoadenosine 10 prepared from guanosine 9, [9, 10] was subject to Sonogashira cross-coupling to generate 11 and introduce the acetylenic functionality. TMS-protected ethynyladenosine (11) was then converted to the required, 6 in a one-pot procedure. [11] A sample of FDEA 8, the anticipated product of enzymatic transhalogenation, was also prepared as a reference compound by protection of the 2ʹ,3ʹ-diol of 11 as an acetonide, and then subsequent fluorination 12 of the primary alcohol and hydrolysis to furnish 8. FDEA 8 was also subjected to co-crystallisation trials with the fluorinase and an X-ray structure was solved to 2.4 Å by molecular replacement using the historical fluorinase refinement. [8] The overlay of the co-crystal structures of 2 and 8 shows 8 (grey, Figure 1 ) bound in the active site in a similar manner to FDA 2 (yellow, with the acetylene at C-2 projecting into the solvent.
Incubation of ClDEA 6 with the fluorinase and L-SeMet, resulted in a conversion to FDEA 8 as illustrated in Scheme 1b (For HPLC profiles see Figure S1a ). The reaction progressed at about 60% of the rate of that of ClDA 4 to FDA 2 (See SI Figure S1b ). This transhalogenation demonstrated that the enzyme does indeed have a specificity weakness at C-2 of adenine. It became immediately attractive to explore extending a polyethylene glycol (PEG) chain from the terminus of the acetylene, as a tether onto a cargo such as a peptide, as a potential strategy for radiolabelling the peptide cargo with fluorine-18. RGD peptides are validated ligands with high affinity to α V β 3 integrin epitopes on the surface of a variety of cancer cells. [13] They have been the focus of many labelling studies for PET, in the development of tumor imaging agents for the clinic, so this seemed a good model to explore. To this end ClDEA-TEG-RGD 15 (TEG = tetraethyleneglycol), emerged as a synthetic target (Scheme 3). The PEG chain was incorporated into the design to project the cyclic peptide into the bulk solvent. A key step involved the Sonogoshira cross-coupling between alkyne 12 and 2-iodoadenosine 10 to generate 13. Reaction of 13 with thionyl chloride gave ClDEA-TEG 14, with a HCl/acetylene addition product (See SI compound 33). The co-product was readily removed from 14 by preparative HPLC. In order to attach the RGD peptide, 14 was subject to a 'click' reaction with c(RGDfK (N 3 ) ), to generate 15, a product which was purified by HPLC and fully characterised (see SI). With the required substrate in hand, 15 was incubated with the fluorinase under the previously established conditions (L-SeMet, F -, fluorinase, pH 7.8) and proved to be a good substrate for the transhalogenation to FDEA-TEG-RGD 16, as monitored by HPLC (Figure 2) . No reaction was observed without enzyme. The identity of 16 was confirmed by both mass spectrometry (See Figure S4) , and against an authentic reference sample which was prepared by synthesis (Scheme 4). The success of this reaction demonstrates that fluorinase mediated transhalogenation can be accomplished with a peptide 'cargo' attached to the terminus of the C-2 acetylenic functional group. This opens up prospects for attaching a variety of peptides to a ClDEA motif, for direct 'last step' fluorine-18 labelling using fluorinase catalysis for PET. O]-water, is dried by ion exchange chromatography, and rendered good for nucleophilic chemistry. Water soluble peptides are most commonly labelled with fluorine-18 after the anhydrous synthesis of reactive small molecules followed by a conjugation to the peptide. These protocols require at least two transformations after securing the [
18 F]-fluoride ion by ion exchange chromatography. However 'last step' fluorination protocols for peptides are less well developed due to the incompatibility of peptides with non-aqueous solvents and a requirement for heating to improve the rate of reactions. Current strategies for the direct labelling of peptides have used fluoride-sequestering strategies. Radiolabelled trifluoroborates [14] have been prepared using aqueous [
18 F]-fluoride and KFH 2 , but at low pH (pH 2), while aluminium hydroxide complexes [16] require heating at elevated temperatures (105 °C) for fluorination. A silicon-based fluoride acceptor approach [15] and direct nucleophilic fluorination reactions [17, 18] at carbon require anhydrous conditions and heating to accomplish fluoride incorporation. It is in this context that fluorinase catalysis presents an attractive strategy for last step fluorination of peptides as no drying of fluoride ion is required and reactions occur at ambient temperature and neutral pH in buffer. Accordingly a transhalogenation reaction is now explored with 15 using [ Figure S5 ). Peptide 16 was evaluated [19] for its ability to bind to α V β 3 integrins. It is clear from Table 1 that 16 retains high affinity to α V β 3 integrin compared with structurally less elaborate cyclic RGD peptides and has significantly higher affinity that the RGD motif itself. [20] Peptide 16 was then injected into a healthy rat to explore if it was robust to defluorination. There was some evidence of metabolism of the peptide, however a combination PET/CT whole body image averaging scans over a 1 h period ( Figure 4 ) did not show radioactivity uptake in the bone indicating that 16 is stable to [
18 F]-fluoride ion release, an important pre-requisite of a PET-tracer. The peptide distribution in different organs was assessed after dissection (see SI Figure S7 ) and had a profile (eg. highest radioactivity in kidney, intestine, spleen and lung) consistent with distribution of an intact RGD motif [21] . 
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